These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27233303)

  • 21. Oxidative stress impairs vasorelaxation induced by the soluble guanylyl cyclase activator BAY 41-2272 in spontaneously hypertensive rats.
    Priviero FB; Zemse SM; Teixeira CE; Webb RC
    Am J Hypertens; 2009 May; 22(5):493-9. PubMed ID: 19247264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma.
    Ghosh A; Koziol-White CJ; Asosingh K; Cheng G; Ruple L; Groneberg D; Friebe A; Comhair SA; Stasch JP; Panettieri RA; Aronica MA; Erzurum SC; Stuehr DJ
    Proc Natl Acad Sci U S A; 2016 Apr; 113(17):E2355-62. PubMed ID: 27071111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41-2272 and BAY 60-2770 alone or in combination with a phosphodiesterase type 5 inhibitor.
    Füllhase C; Hennenberg M; Sandner P; Strittmatter F; Niedworok C; Bauer RM; Gratzke C; Soler R; Stief C; Andersson KE
    Neurourol Urodyn; 2015 Nov; 34(8):787-93. PubMed ID: 25230878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble Guanylate Cyclase-Mediated Relaxation in Aortas from Rats with Renovascular Hypertension.
    Tawa M; Shimosato T; Nakagawa K; Okamura T; Ohkita M
    Pharmacology; 2022; 107(3-4):235-240. PubMed ID: 34929695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble Guanylate Cyclase Modulators, BAY 41-2272 and BAY 60-2770, Inhibit Human and Rabbit Prostate Contractility.
    Calmasini FB; Alexandre EC; Silva FH; De Nucci G; Antunes E; D'Ancona CA; Mónica FZ
    Urology; 2016 Aug; 94():312.e9-312.e15. PubMed ID: 27131967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine (BAY 41-2272) on smooth muscle tone, soluble guanylyl cyclase activity, and NADPH oxidase activity/expression in corpus cavernosum from wild-type, neuronal, and endothelial nitric-oxide synthase null mice.
    Teixeira CE; Priviero FB; Webb RC
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1093-102. PubMed ID: 17596536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct sGC activation bypasses NO scavenging reactions of intravascular free oxy-hemoglobin and limits vasoconstriction.
    Raat NJ; Tabima DM; Specht PA; Tejero J; Champion HC; Kim-Shapiro DB; Baust J; Mik EG; Hildesheim M; Stasch JP; Becker EM; Truebel H; Gladwin MT
    Antioxid Redox Signal; 2013 Dec; 19(18):2232-43. PubMed ID: 23697678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of peroxynitrite on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
    Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
    J Vasc Res; 2014; 51(6):439-46. PubMed ID: 25634663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the relaxant effect of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in isolated detrusor smooth muscle.
    Báu FR; Mónica FZ; Priviero FB; Baldissera L; de Nucci G; Antunes E
    Eur J Pharmacol; 2010 Jul; 637(1-3):171-7. PubMed ID: 20399768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.
    Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E
    Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The soluble guanylyl cyclase activator BAY 60-2770 ameliorates overactive bladder in obese mice.
    Leiria LO; Silva FH; Davel AP; Alexandre EC; Calixto MC; De Nucci G; Mónica FZ; Antunes E
    J Urol; 2014 Feb; 191(2):539-47. PubMed ID: 24050894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The sGC activator BAY 60-2770 has potent erectile activity in the rat.
    Lasker GF; Pankey EA; Frink TJ; Zeitzer JR; Walter KA; Kadowitz PJ
    Am J Physiol Heart Circ Physiol; 2013 Jun; 304(12):H1670-9. PubMed ID: 23585129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of relaxation and interaction with nitric oxide of the soluble guanylate cyclase stimulator BAY 41-2272 in mouse gastric fundus and colon.
    Cosyns SM; Lefebvre RA
    Eur J Pharmacol; 2012 Jul; 686(1-3):104-15. PubMed ID: 22575520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation.
    Jones AW; Durante W; Korthuis RJ
    J Pharmacol Exp Ther; 2010 Oct; 335(1):85-91. PubMed ID: 20605906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble guanylate cyclase activator BAY 54-6544 improves vasomotor function and survival in an accelerated ageing mouse model.
    Ataei Ataabadi E; Golshiri K; Jüttner AA; de Vries R; Van den Berg-Garrelds I; Nagtzaam NMA; Khan HN; Leijten FPJ; Brandt RMC; Dik WA; van der Pluijm I; Danser AHJ; Sandner P; Roks AJM
    Aging Cell; 2022 Sep; 21(9):e13683. PubMed ID: 36029161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
    Evgenov OV; Kohane DS; Bloch KD; Stasch JP; Volpato GP; Bellas E; Evgenov NV; Buys ES; Gnoth MJ; Graveline AR; Liu R; Hess DR; Langer R; Zapol WM
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1138-45. PubMed ID: 17872487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effect of the soluble guanylyl cyclase stimulator BAY 41-2272 on impaired penile erection in db/db-/- type II diabetic and obese mice.
    Nunes KP; Teixeira CE; Priviero FB; Toque HA; Webb RC
    J Pharmacol Exp Ther; 2015 May; 353(2):330-9. PubMed ID: 25740897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
    Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
    Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide.
    Zhou Z; Martin E; Sharina I; Esposito I; Szabo C; Bucci M; Cirino G; Papapetropoulos A
    Pharmacol Res; 2016 Sep; 111():556-562. PubMed ID: 27378567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling.
    Beyer C; Zenzmaier C; Palumbo-Zerr K; Mancuso R; Distler A; Dees C; Zerr P; Huang J; Maier C; Pachowsky ML; Friebe A; Sandner P; Distler O; Schett G; Berger P; Distler JH
    Ann Rheum Dis; 2015 Jul; 74(7):1408-16. PubMed ID: 24567525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.